
    
      This Phase 1, Repeat Insult Patch Test (RIPT) study is a single-center study of topical
      SM04755 solution repetitively applied to skin of healthy volunteers. This study will assess
      the potential of the Test Materials to induce contact sensitization as measured by treatment
      emergent adverse events (TEAEs), Reaction Grade and Investigator assessment of irritation and
      sensitization.
    
  